Investor Relations
The investor pages that follow are your resource for financial information about Aastrom Biosciences, Inc.. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.
Recent Releases
06-18-09
FDA Removes Clinical Hold From Aastrom Phase II IMPACT-DCM Clinical Trial
05-22-09
Aastrom Proactively Places Phase II IMPACT-DCM Clinical Trial On Hold Following Report of Serious Adverse Event
more »
Events
08-09-09
2009 4th Medical Biotech Forum
08-05-09
BMO Capital Markets 9th Annual Focus on Healthcare Conference
more »
|